Literature DB >> 16849738

Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.

G B Christakis, S Perlorentzou, P Alexaki, A Megalakaki, I K Zarkadis1.   

Abstract

A case of central venous catheter-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myelogenous leukaemia is reported. The patient was successfully treated with amikacin and piperacillin-tazobactam. The clinical isolate was identified as R. mucosa by 16S rRNA gene sequencing.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16849738     DOI： 10.1099/jmm.0.46634-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


  5 in total

1.  Peritonitis and technique failure caused by Roseomonas mucosa in an adolescent infected with HIV on continuous cycling peritoneal dialysis.

Authors:  Mary Adetinuke Boyd; Matthew B Laurens; Paul D Fiorella; Susan R Mendley
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

2.  Roseomonas sp. isolated from ticks, China.

Authors:  Wei Liu; Fang Zhang; Er Chen Qiu; Jun Yang; Zhong Tao Xin; Xiao Ming Wu; Fang Tang; Hong Yang; Wu Chun Cao
Journal:  Emerg Infect Dis       Date:  2010-07       Impact factor: 6.883

3.  Draft Genome Sequence of Roseomonas mucosa Strain AU37, Isolated from a Peripheral Intravenous Catheter.

Authors:  Md Abu Choudhury; Alexander M Wailan; Hanna E Sidjabat; Li Zhang; Nicole Marsh; Claire M Rickard; Mark R Davies; David J McMillan
Journal:  Genome Announc       Date:  2017-04-13

4.  The ignored diversity: complex bacterial communities in intensive care units revealed by 16S pyrosequencing.

Authors:  Lisa Oberauner; Christin Zachow; Stefan Lackner; Christoph Högenauer; Karl-Heinz Smolle; Gabriele Berg
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

5.  Two Cases of Bacteremia Due to Roseomonas mucosa.

Authors:  Yu Kyung Kim; Jung Suk Moon; Kyung Eun Song; Won Kil Lee
Journal:  Ann Lab Med       Date:  2016-07       Impact factor: 3.464
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.